Sugar alcohol sorbitol may supercharge chemo and immunotherapy for stomach cancer

NCT ID NCT06826079

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study tests whether taking oral sorbitol, a common sugar alcohol, can enhance the effects of standard chemotherapy and an immunotherapy drug (tirellizumab) in people with locally advanced stomach cancer. Eighty participants will receive either sorbitol or a placebo alongside their cancer treatment for three months. The goal is to see if sorbitol increases the number of patients whose tumors shrink significantly before surgery.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
sorbitol
What this could lead to
If it works, this could point toward a simple, cheap way to make standard cancer treatments more effective for gastric cancer patients.
What could go wrong
This is an early phase 2/3 trial with only 80 participants. Sorbitol is a sugar alcohol, and high doses may cause digestive side effects like bloating or diarrhea. The benefit is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology

    RECRUITING

    Wuhan, Hubei, 470000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.